TrialRespiratory research2020

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.

Eulalia Jimenez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.